<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02435771</url>
  </required_header>
  <id_info>
    <org_study_id>359128-8</org_study_id>
    <nct_id>NCT02435771</nct_id>
  </id_info>
  <brief_title>Efficacy Of Ergocalciferol In Adults According To BMI</brief_title>
  <official_title>Efficacy Of Ergocalciferol In Adults According To BMI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Walter Reed National Military Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Walter Reed National Military Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vitamin D insufficiency is an increasing trend in the United States. According to the NHANES&#xD;
      data collection there was a near doubling of patients with vitamin D deficiency in 10 years.&#xD;
      Vitamin D deficiency is associated with several adverse outcomes such as increased fractures,&#xD;
      certain microbial diseases, cardiovascular diseases, and metabolic dysfunction. The&#xD;
      increasing prevalence of vitamin D deficiency has been attributed to the increasing&#xD;
      prevalence of obesity. Several studies have shown that obese patients have lower 25-OH&#xD;
      vitamin D (25-OHD) levels compared to nonobese patients and obese patients require more&#xD;
      vitamin D compared to nonobese patients. The most commonly prescribed medication to replete&#xD;
      vitamin D deficiency is oral ergocalciferol. To date, no prospective trials have been&#xD;
      published to evaluate a standard protocol in the treatment of vitamin D insufficiency in&#xD;
      adults.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    failed to meet enrollment goals&#xD;
  </why_stopped>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">April 2017</completion_date>
  <primary_completion_date type="Actual">April 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>serum 25-hydroxy-vitamin D level</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Obesity</condition>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>BMI &lt;25</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Normal BMI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BMI 25-35</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Overweight and obese by BMI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BMI &gt;35</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Obese by BMI</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ergocalciferols</intervention_name>
    <description>Treatment 1- 400,000 IU</description>
    <arm_group_label>BMI 25-35</arm_group_label>
    <arm_group_label>BMI &lt;25</arm_group_label>
    <arm_group_label>BMI &gt;35</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ergocalciferols</intervention_name>
    <description>Treatment 2- 800,000 IU</description>
    <arm_group_label>BMI 25-35</arm_group_label>
    <arm_group_label>BMI &lt;25</arm_group_label>
    <arm_group_label>BMI &gt;35</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Study subjects have to be between the ages of 18 to 65 with a serum 25OHD level less&#xD;
             than 20 ng/ml.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participants will be excluded if they have any of the following:&#xD;
&#xD;
               1. Due to the inaccuracies of BMI in patients with increased muscle mass, in group&#xD;
                  with a BMI 25-35: men with a waist circumference &lt; 90 cm ; women &lt; 80 cm&#xD;
&#xD;
               2. Chronic liver disease defined by any clinical or a history of serum AST or ALT &gt;&#xD;
                  2 times ULN&#xD;
&#xD;
               3. Kidney disease defined as a GFR &lt;60 ml/min&#xD;
&#xD;
               4. Sarcoidosis&#xD;
&#xD;
               5. Any known malignancy&#xD;
&#xD;
               6. Known malabsorption disorder to include inflammatory bowel disease, celiac&#xD;
                  disease, cystic fibrosis, history of gastric bypass&#xD;
&#xD;
               7. Primary hyperparathyroidism or hypercalcemia,&#xD;
&#xD;
               8. Patients that are pregnant or considering pregnancy.&#xD;
&#xD;
               9. Patients taking certain medications such as glucocorticoids, anti-seizure&#xD;
                  medications such has phenobarbital or phenytoin or patients taking antiviral&#xD;
                  medications for HIV as these are known to cause vitamin D deficiency&#xD;
&#xD;
              10. Individuals excluded from having a DXA scan&#xD;
&#xD;
        Study participants will be excluded from having a DXA scan if any of the following:&#xD;
&#xD;
          1. Any amputation of a extremity including toes&#xD;
&#xD;
          2. If they have a pacemaker, automatic defibrillator, coronary stents or metal suture&#xD;
             material in the heart&#xD;
&#xD;
          3. If they have artificial joints, pins, plate or any other type of metal objects&#xD;
&#xD;
          4. If they have received contrast material such as barium in the past 7 days&#xD;
&#xD;
          5. If they have had a nuclear medicine study in the past 3 days&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alicia L Warnock, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>WRNMMC-B</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Patrick W Clyde, MD</last_name>
    <role>Study Director</role>
    <affiliation>WRNMMC-B</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vinh Mai, MD</last_name>
    <role>Study Chair</role>
    <affiliation>WRNMMC-B</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Verna Parchment</last_name>
    <role>Study Chair</role>
    <affiliation>WRNMMC-B</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Walter Reed National Military Medical Center</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20889</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <study_first_submitted>May 21, 2013</study_first_submitted>
  <study_first_submitted_qc>April 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2015</study_first_posted>
  <last_update_submitted>May 10, 2017</last_update_submitted>
  <last_update_submitted_qc>May 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>October 18, 2018</submitted>
    <returned>November 14, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

